Abstract

Host health depends on the intestinal homeostasis between the innate/adaptive immune system and the microbiome. Numerous studies suggest that gut microbiota are constantly monitored by the host mucosal immune system, and any slight disturbance in the microbial communities may contribute to intestinal immune disruption and increased susceptibility to inflammatory bowel disease (IBD), a chronic relapsing inflammatory condition of the gastrointestinal tract. Therefore, maintaining intestinal immune homeostasis between microbiota composition and the mucosal immune system is an effective approach to prevent and control IBD. The overall theme of this review is to summarize the research concerning the pathogenesis of IBD, with particular focus on the factors of gut microbiota-mucosal immune interactions in IBD. This is a comprehensive and in-depth report of the crosstalk between gut microbiota and the mucosal immune system in IBD pathogenesis, which may provide insight into the further evaluation of the therapeutic strategies for IBD.

Highlights

  • The exact pathogenesis of inflammatory bowel disease (IBD) is still elusive, but it is generally accepted that the inflammation results from a defective mucosal immune response to intestinal flora in genetically susceptible individuals [1]

  • Immune system–microbiota interactions act as a double-edged sword, with the microbiota being beneficial to the host in normal conditions, and potentially causing adverse effects in the host that contribute to inflammation [168]

  • The gut microbiota is constantly monitored by the mucosal immune system, and any slight disturbance in the gut microbiota may contribute to intestinal immune disruption and increased susceptibility to IBD [169]

Read more

Summary

Introduction

The exact pathogenesis of inflammatory bowel disease (IBD) is still elusive, but it is generally accepted that the inflammation results from a defective mucosal immune response to intestinal flora in genetically susceptible individuals [1]. A common type of IBD is Crohn’s disease (CD), in which inflammation is usually transmural and can be found in any area of the gastrointestinal tract Another major type of IBD, ulcerative colitis (UC), is characterized by a non-transmural inflammation that usually affects the colon and rectum [2]. Since urbanization and rapid industrialization in developing countries, traditional lifestyles have changed greatly [4]. Several lines of evidence support the hypothesis that disturbance of the relationship between the gut microbiota and the mucosal immune system is involved in IBD pathogenesis [6,7,8].

Specific Pathogenic Microbes in IBD
Profiles of the Intestinal Bacteria and IBD
Fungal Microbiota and IBD
Enteric Virome and IBD
Protozoans and IBD
Helminths and IBD
Composition of the Mucosal Immune System
Mucus Layer
Single Layer of IECs
Intestinal Immune Cells
Orchestrated Balance between Mucosal Immune System and Gut Microbiota
TLRs and the Gut Microbiota
NLRs and the Gut Microbiota
Findings
Discussion and Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.